Investorideas.com - Cannabis Stock News: 1933 Industries (CSE: TGIF) (OTCQX: TGIFF) Reports First Quarter Financial Results for Fiscal Year 2020
www.investorideas.com - news that inspires big ideas
Tuesday, 31 December 2019
Monday, 30 December 2019
Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis
Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)
Investor
Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V),
(CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)
Delta, Kelowna, BC, December 30, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12301BEV-AMRS-KHRN-OILS-APHA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
BevCanna
Enterprises Inc. (CSE:BEV) (OTCQB:
BVNNF) announced that is
has increased the size of its outdoor cannabis cultivation site to 292 acres,
up from the originally announced 130 acre site. BevCanna has partnered with
agricultural experts Clearwater CannGrow Ltd. to grow certified organic
sun-grown cannabis on the property near Osoyoos, British Columbia.
This
expansion of cultivatable land will allow BevCanna to develop into one of
largest outdoor cannabis cultivators in Canada. The Company has in turn
increased its anticipated production to 300,000 kg - 400,000 kg of biomass, and
a yield of 30,000 kg – 40,000 kg of pure cannabinoids through the finished extract.
"Interest
in our BC sun grown cannabis has been exceptionally strong, and we're expanding
our cultivation and production capabilities to meet the anticipated
demand," said John Campbell, Chief Strategy Officer at BevCanna. "The
increased capacity will position BevCanna well to become a leader in the
production of high-quality, next-generation products, in the lead-up to
Canada's commercialization of such products in 2020."
In
conjunction with the additional cultivation capacity, BevCanna has completed a
debt settlement with cultivation partner Clearwater CannGrow, in the amount of
$500,000, in exchange for the issuance of 1,000,000 common shares at a deemed
price of $0.50 per Share.
"We're
very pleased to further strengthen our relationship with Clearwater
CannGrow," said John Campbell, Chief Strategy Officer at BevCanna.
"Clearwater CannGrow's direct expenditures into our agricultural operation
are an incredible sign of confidence and commitment to the operation, and to
BevCanna as a whole."
The
Shares issued in the debt settlement are subject to resale restrictions imposed
by applicable law or regulation, including a statutory hold period expiring
four months and one day from the date of closing of the debt settlement.
Amyris, Inc. (NASDAQ:
AMRS), a leader in the development and production of
sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors
& Fragrances markets, reported that it
has successfully shipped the first cannabinoid to its partner, LAVVAN. Amyris
is also well on its way to the shipment of a second cannabinoid in the first
half of 2020.
These
ingredients are produced with Amyris's fermentation technology platform
delivering the leading quality and high purity at a significantly reduced cost
relative to cannabis plant grown and derived ingredients. The company's
technology allows Amyris to scale ingredients that are rarer within the
cannabis plant, and difficult and extremely expensive to extract in quantity.
This is the 10th unique fermentation molecule Amyris has currently
in production. Amyris is a market leader in Clean Beauty and natural
ingredients from fermentation and currently has 22 additional molecules in
development with some of the world's leading companies as partners and
long-term supply and commercialization agreements to ensure successful market
entry.
The
company also announced that it has agreed on business terms for a partnership
with a leading Asian pharmaceutical company to develop and scale a breakthrough
target for a rare oncology treatment. In addition to the success in
cannabinoids and the new opportunity in oncology the company has also agreed to
significantly expand its current collaboration with its Chinese partner for
vitamins. Amyris plans to provide further details on these agreements at an
investor update meeting to be scheduled in February. These new agreements
represent several millions of dollars in collaboration payments annually for
the next several years. Biossance is also having an excellent quarter with Biossance.com now
representing about 50% of Biossance revenue and Sephora continuing to deliver
excellent growth.
"We
are very pleased to end 2019 with strong operational performance and business
momentum," said John Melo, President and CEO of Amyris. "We plan to
continue building on our position as the leading synthetic biology company by
continuing to deliver the highest purity and most sustainably sourced
ingredients for the Health, Beauty and Flavor and Fragrance industries. Our
brands are delivering the leading products in their respective categories and
this is helping us deliver an excellent quarter. We expect to have our
financing needs behind us early in 2020 and a strong year of profitable
growth."
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) welcomed the
Colombian government's announcement that the country has been awarded a record
high quota of 21.84% of worldwide high -THC for commercial and scientific
purposes. The quota, which is awarded by the International Narcotics Control
Board ("INCB"), an independent body for the implementation of the
United Nations Drug Convention, affirms Colombia's role as one of the most
important supply sources for the licensed global cannabis economy.
Established
in 1961, the INCB, who's members are made up of global government agencies and
representatives of the World Health Organization, plays an important role in
monitoring enforcement of restrictions on narcotics and psychotropics and in
deciding which jurisdictions should be regulated. The quota allocation of 56.5
tons of dry flower for Colombia in 2020, affirms that the international
community governing legalized narcotics recognizes the important work of the
Colombia government in establishing an effective regulatory framework to
support national and worldwide cannabis demand.
Juan
Diego Alvarez, Khiron Vice President of Regulatory Affairs, stated "As the
only company with an authorized high-THC quota for cultivation in 2019 to meet
the needs of patients in Colombia, we welcome the INCB announcement and
congratulate the Government of Colombia on the achievement. The 2020 quota
guarantees access to new medical products that can transform patients'
lives."
Khiron
Life Sciences is currently the only cannabis company in Colombia with an
allocation of quota to manufacture psychoactive medical cannabis for commercial
domestic purposes, and one of the few companies also authorized to meet export
demand. As previously announced, the authorization is a result of commercial
quotas allocated to Khiron by the Colombian Technical Quotas Group
("TQG"), which permit the Company to cultivate and commercialize up
to 560 kg – or approximately, 65,000 units – of psychoactive, high-THC cannabis
in 2019. As of April 2019, Khiron has applied for additional commercial quotas
for high-THC cannabis for 2020. TQG decisions on commercial quotas for the year
are anticipated to be announced by February 2020.
Nextleaf Solutions
Ltd.
(CSE:
OILS) (OTCQB:
OILFF) announced that
the Canadian Intellectual Property Office has granted the Company a patent for
its proprietary filtration stack used in the post-extraction processing of THC
and CBD oils. Nextleaf has been issued a total of 11 patents by four
international patent offices in the key markets of Canada, the United States of
America, Australia, and Colombia.
"Given
the abundant supply of lower-grade dried cannabis, we believe processors that
establish a competitive advantage by utilizing superior technology to transform
otherwise unsellable biomass into high-purity THC and CBD oils at a lower cost
than competitors, will generate better margins and build a sustainable long
term business," said Paul Pedersen, CEO of Nextleaf Solutions. "As we
close out 2019, I'm extremely proud of our R&D team for obtaining its 11th
patent, protecting what we believe to be the most efficient methods for
producing distilled THC and CBD oil at scale within a regulated
environment," continued Pedersen.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) will
release their financial results for its second quarter and six
months ended November 30, 2019 on January 14, 2020 before market open.
Aphria
executives will host a conference call to discuss these results at 8:00 am
Eastern Time. To listen to the live call, dial (888) 231-8191 from Canada and
the U.S. or (647) 427-7450 from International locations and use the passcode
1575423. A telephone replay will be available approximately two hours after the
call concludes through January 28, 2020. To access the recording dial (855)
859-2056 and use the passcode 1575423.
There
will also be a simultaneous, live webcast available on the Investors section of
Aphria's website at aphriainc.com. The
webcast will be archived for 30 days.
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Friday, 27 December 2019
Investorideas.com - Cannabis Stock News: BevCanna (CSE:BEV, Q:BVNNF) Expands Outdoor Cannabis Cultivation Capabilities to Almost 300 acres
Investorideas.com - Cannabis Stock News: BevCanna (CSE:BEV, Q:BVNNF) Expands Outdoor Cannabis Cultivation Capabilities to Almost 300 acres
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Monday, 23 December 2019
Investorideas.com - Cannabis Stock News: Aurora Cannabis (NYSE: $ACB) (TSX: $ACB.TO) Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
Investorideas.com - Cannabis Stock News: Aurora Cannabis (NYSE: $ACB) (TSX: $ACB.TO) Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Friday, 20 December 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $BEV.C) (TSX: $FAF.TO) (OTCQB: $GBLX) (NASDAQ: $NBEV)
Investor Ideas #Potcasts;
#Cannabis News and #Stocks on the Move; (CSE: $BEV.C) (TSX:
$FAF.TO) (OTCQB: $GBLX) (NASDAQ: $NBEV)
Delta, Kelowna, BC, December 20, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12201BEV-FAF-GBLX-NBEV.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
BevCanna
Enterprises Inc. (CSE:BEV) (OTC :BVNNF) announced today that it has exercised its
option to acquire the right, title and interest to DeeperGreen™, the
proprietary water-soluble cannabinoid powder ingredient developed by partner
Greener Frontiers.
"DeeperGreen
technology expands BevCanna's ability to produce a portfolio of cannabis
infused beverage formats," said Emma Andrews, Chief Commercialization Officer
at BevCanna. "The addition of a water-soluble powder allows us to offer
consumers more variety in methods of consumption, which can now pair with
various consumption occasions. Powdered drink mixes complement our existing
expertise in ready-to-drink products and allow us to expand the innovation
pipeline for our house brands, and with white label partners through contract
manufacturing."
DeeperGreen
converts extracted cannabis into a fast-acting, tasteless, odorless,
water-soluble powdered ingredient, and has been proven to be a stable
ingredient that when tested with cannabinoids, consistently delivers target
concentrations within one batch and from batch-to-batch. Independent laboratory
testing has also confirmed that DeeperGreen precisely infuses granular drink
mixes and ready-to-drink water beverages.
Tests
have confirmed that DeeperGreen, and products infused with DeeperGreen, meet
the criteria to pass the current Cannabis Compliance Regulations set in
California, and will allow for reliable water-soluble infusion manufacturing
processes and dosing confidence for consumers.
On
December 18th, 2019, the Company entered into an amendment agreement to the
Cannabis Beverage Joint Development Agreement dated April 1, 2019 with Greener
Frontiers Corporation and BevCanna US Operating Company Ltd., a wholly-owned
subsidiary of the Company. Pursuant to the Agreement, the Company exercised its
right under the JD Agreement to purchase all of the right, title, and interest
in and to DeeperGreen and certain other intellectual property assets of Greener
Frontiers.
Fire & Flower
Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire
& Flower Inc. today announced that it has begun selling new
"cannabis 2.0" product formats in its retail stores in the province
of Saskatchewan.
The
Company is among the first retailers in Canada to be selling these new product
formats. This has been achieved through a private wholesale model in the
province of Saskatchewan, where the Company's wholly-owned distribution
business, Open Fields Distribution purchases from and negotiates prices
directly with Licensed Producers.
New
product formats in Fire & Flower's assortment will be composed of edibles
including gummies, mints and chocolates; and concentrate vaporizers in both
all-in-one and cartridge formats. Fire & Flower's initial assortment of
cannabis 2.0 products in the province is anticipated to include offerings from
the following Licensed Producers and brands prior to the end of 2019: Aphria,
Aurora, Dosist, Cronos, The Green Organic Dutchman, High Park, Organigram,
Redecan, and Sundial.
"With
Fire & Flower being one of the first retailers in Canada to stock new
cannabis formats, this exemplifies the clear benefits of the private
distribution model including price, access and diversity of product within the
province of Saskatchewan," shared Trevor Fencott, Fire & Flower's
Chief Executive Officer. "We have demonstrated leadership through
establishing Open Fields Distribution which supplies both the Fire & Flower
retail network and external accounts within the province of Saskatchewan. There
is significant demand for these new product formats in the market and we look
forward to bringing these products to our loyal customers."
"Our
team has worked diligently over the last year and we are thrilled to be
launching our Solei, RIFF and Good Supply vaporizers in 510 and all-in-ones at Fire
& Flower stores across the province of Saskatchewan," said Bernie
Yeung, Vice President, Sales & Channel Strategy with Aphria Inc. "We
are confident in our market readiness across the country and look forward to
working closely with our retail partners to ensure we have the right brands and
product offerings for consumers as we strive to combat the illicit
market."
Fire
& Flower will continue to monitor consumer preferences of new product
formats using the Hifyre digital retail and analytics platform to judiciously
manage its product assortment and inventory on-hand.
As
new products, including beverages and topcials, become available, Fire &
Flower expects to include these products in the Company's assortment, thereby
increasing consumer choice of new product formats.
The
Company does not yet have a confirmed date for the release of new cannabis
product formats in provinces where government-owned provincial distributors
control the supply chain.
GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for
their Parkinson's disease formulations from the midterm report for their
preclinical study being performed by Dr. Lee Ellis of the National Research
Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations
were able to reduce behavioral changes associated with the loss of
dopamine-producing neurons, which underlies the pathology of Parkinson's
disease in the animal model. Our final phase of testing will study the
mechanism of action for these promising formulations, which could potentially
help patients with this debilitating disease. The combined direct and indirect
costs associated with Parkinson's disease are estimated at $52 billion in the
U.S. alone.
"Several
of GB Sciences' mixtures were effective. In fact, our most effective mixture
was able to 'rescue' the PD-like behavioral changes to the point where the
treated animal's behavior was back to baseline. In addition, our PD formulas
produced negligible side effects, which is equally important," explained
Dr. Andrea Small-Howard, Chief Science Officer and Director of both GB
Sciences, Inc. and GBS Global Biopharma, Inc. "These important preclinical
results will be included as 'proof of concept' in GB Sciences' Investigational
New Drug application with the US FDA in order to enter into our 'First-in-Man'
human clinical trial as early as next year."
Central
to the development of Parkinson's disease is the loss of dopamine-producing
neurons. Reduced dopamine levels in the brain lead to movement disorders. GB
Sciences' PD formulations may be protecting dopamine-producing neurons, or they
may cause the surviving neurons to produce more dopamine to compensate for a
loss in the number of dopamine-producing neurons. The final phase of GB
Sciences' preclinical study will examine these and other possible mechanisms
for their effectiveness.
"These
positive preclinical results suggest that our cannabinoid-containing complex
mixtures may be useful for the treatment of Parkinson's disease
symptomology," said Dr. Michael Farley, President and Director of GBS
Global Biopharma, Inc.. "We look forward to bringing these promising
formulations into human clinical trials as early as 2020."
New Age Beverages
Corporation (NASDAQ: NBEV), the Colorado-based healthy
products company, announced the launch of its hemp portfolio in
Australia and New Zealand.
Under
the umbrella of its Health Sciences Division, NewAge received approval and has
begun selling its premium portfolio of hemp oils, creams and lotions in
Australia and New Zealand. The launch initially features three distinct
products:
- ‘NHANCED Hemp Body Cream in a 120 mL tub
- ‘NHANCED Hemp Roll-On Gel 90 mL roll-on
- ‘NHANCED Hemp Oil containing 30 mL tincture
The
products will be sold immediately through more than 2,000 direct-to-consumer distribution
partners across Australia and New Zealand.
“’NHANCED
Hemp is proving to be one of our most talked about product lines we have
launched,” said Brent Willis, Chief Executive Officer of NewAge. “Receiving
approval and beginning to sell our products in these markets further puts us on
the right path to become a leading player in the hemp/CBD industry in Australia
and New Zealand.”
NewAge’s
research and development teams and scientists worked exhaustively over the past
year to develop the hemp specific formulas that both meet the regulatory
requirements of markets like Australia and New Zealand but also maintained the
efficacy, strength, and benefit of NewAge’s full strength CBD formulas.
“’NHANCED
Hemp products were designed and developed to meet stringent government hemp (cannabis sativa) and cannabidiol (CBD)
regulations for safety, purity and efficacy,” said Laura Kimball, director of
product development. “The hemp in these three products is sourced from
industrial hemp grown in the USA and the mature seed is then carefully
processed to ensure that it is pure and completely free from
tetrahydrocannabinol (THC).”
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Investor Ideas adds New #Cannabis #Stocks (OTC: $PHBI) (CSE: $TFC.C) (CSE: $MJAR.C)(TSXV: $EVE.V)
Investor Ideas adds New #Cannabis
#Stocks (OTC: $PHBI) (CSE: $TFC.C) (CSE: $MJAR.C)(TSXV: $EVE.V)
Point Roberts, WA, Delta BC – December 20, 2019 – Investorideas.com, a global news source and investor resource covering cannabis and hemp
stocks announces this week’s additions to its cannabis /hemp stock directory for investors
following the sector.
Read this news in full at https://www.investorideas.com/news/2019/cannabis/12201PHBI-TFC-MJAR-EVE.asp
This week’s new companies are involved in tissue cultures
working with hemp plants, specialty finance for the cannabis industry, cannabis
management platforms and the production and sale of various cannabis products.
MJardin Group, Inc (CSE:
MJAR) (OTCQX:
MJARF) is a cannabis management platform with
extensive experience in cultivation, processing, distribution and retail. For
over 10 years, MJardin has refined cultivation methodologies, developed state
of the art facilities and implemented vertical integration for and on behalf of
license owners. MJardin is based in Denver, Colorado and Toronto, Canada.
Pharmagreen
Biotech, Inc. (OTC
Pink: PHBI) WFS Pharmagreen Inc. is a wholly owned
Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded (OTC
Pink: PHBI) company. WFS Pharmagreen Inc. is a tissue culture company that is
becoming one of the largest producers of hemp plantlets through a proprietary
tissue culture process with opportunity to become one of the largest players
globally. Pharmagreen's mission is to advance the technology of tissue culture
science and to provide the highest quality 100% germ free, disease free and all
genetically the same hemp plantlets with high Cannabinoids content and with less
than 0.3% THC and other flora while offering full spectrum DNA testing for
plant identification, live genetics preservation using low temperature storage
for various plant species.
Trichome Financial Corp. (CSE:TFC)
is a specialty finance company focused on
providing flexible and creative credit solutions to the global legal cannabis
market. Trichome Financial was created to address the lack of credit
availability in the large, growing and increasingly complex cannabis market.
Founded by industry leaders Origin House and Stoic Advisory, Trichome
Financial's experienced management team has a unique edge to capitalize on
proprietary deal flow and industry insight while developing a first mover
advantage as a global cannabis focused specialty finance company. Trichome
Financial provides customized financing solutions across the industry value
chain to support growth, capital expenditures, mergers, acquisitions, working
capital and other needs. Leveraging the combined resources and knowledge
of its founders, it is able to offer significant value-added financial,
product, market and operational support to its partner companies. Trichome
Financial's current assets are all based in Canada and
it currently has no operations or assets in the
United States.
Eve & Co
Incorporated (TSXV:EVE,OTC:EEVVF) through its wholly-owned subsidiary Natural MedCo Ltd.,
holds cultivation and processing licences under the Cannabis Act (Canada) for
the production and sale of various cannabis products, including dried cannabis,
cannabis plants and extraction of cannabis oil. Natural MedCo Ltd. was Canada's
first female-founded licensed producer of medicinal marijuana and received its
cultivation licence from Health Canada in 2016. Eve & Co is led by a team
of agricultural experts and has a licensed 1,000,000 square foot greenhouse
located in Strathroy, Ontario.
For investors following the sector Investor Ideas has
created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE,
ASX Marijuana / Hemp Stocks. Visit directory.
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail
investors a wide variety of stocks to review.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About Investorideas.com - News
that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports
biotech, water, renewable energy and more. Investor Idea’s original branded
content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not
condone the use of cannabis except where permissible by law. Our site does not
possess, distribute, or sell cannabis products.
Learn more about our news, PR and social media
services at Investorideas.com
Follow
us on cannabis social media
To sponsor a daily podcast for the month or to be an expert guest please
contact us!
Contact
Investorideas.com
800-665-0411
Get more Marijuana, hemp
& cannabis stock investor ideas- news, articles, podcasts
and stock directories
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...